Ab­b­Vie, Eli Lil­ly quit UK's vol­un­tary drug pric­ing agree­ment, send­ing 'warn­ing sig­nal' to UK gov­ern­ment

Ma­jor phar­mas Eli Lil­ly and Ab­b­Vie have ex­it­ed the UK Na­tion­al Health Ser­vice’s vol­un­tary med­i­cine pric­ing agree­ment, cit­ing un­jus­ti­fi­able rev­enue claw­backs, the As­so­ci­a­tion of the British Phar­ma­ceu­ti­cal In­dus­try an­nounced Mon­day.

In De­cem­ber, the UK gov­ern­ment said com­pa­nies with brand­ed med­i­cines un­der the vol­un­tary agree­ment will have to re­turn al­most £3.3 bil­lion in sales rev­enue to the gov­ern­ment, a sig­nif­i­cant jump from £0.6 bil­lion in 2021 and £1.8 bil­lion in 2022.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.